Pregnancy outcomes for new ART regimens
- PMID: 37001537
- DOI: 10.1016/S2352-3018(23)00077-2
Pregnancy outcomes for new ART regimens
Conflict of interest statement
ML reports grants and non-financial support from ViiV Healthcare and grants from Janssen Pharmaceutica, outside the submitted work. BC reports financial support from the National Institutes of Health and the European and Developing Countries Clinical Trials Partnership and declares no conflicts of interest.
Comment on
-
Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.Lancet HIV. 2023 May;10(5):e284-e294. doi: 10.1016/S2352-3018(23)00047-4. Epub 2023 Mar 28. Lancet HIV. 2023. PMID: 37001536 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
